Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.9.3

Document information
Reference	ICH ICH E6 Guideline R3 (2025)
Validity area	ICH
Scope(s)	HM
Document name	ICH E6 Guideline
Version / Revision	R3 (2025)
Status	Current
Document type	International guideline
Language(s)	EN
Description	GUIDELINE FOR GOOD CLINICAL PRACTICE
Official source	Official link
Restricted access	No
Submitted by	Florian Adragna
Contributors

Reference Details
Module	Module 3 — Unit 3.3.1
Scope	G
Document part	III. Annex 1 2.9.3
Language	EN
Original entry by	Florian Adragna
Contributors
Tags	Unblinding, Blinding, Trial participant, Investigator responsibilities
Comment	Subject right to know treatment assignment at end of trial

Content

2.9 End of Participation in a Clinical Trial [...] 2.9.3 Where relevant, the investigator should inform the participant about the trial results and treatment received when this information is available from the sponsor after unblinding, with due respect to the participant’s preference to be informed.